This announcement is a separate document:
上海市通力律师事务所关于翔宇医疗2024年限制性股票激励计划（草案）的法律意见书
Legal Opinion of Shanghai Tongli Law Firm on Xiangyu Medical\'s 2024 Restricted Stock Incentive Plan (Draft)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.